REKLAIM, A Phase Ib Clinical Trial Using a Novel Immune Modulation Strategy for Systemic Administration of FBX-101 (aavrh10.galc) after Umbilical Cord Blood Transplantation for the Treatment of Infantile Krabbe Disease
MOLECULAR THERAPY（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要